Metropolis Healthcare stock is down 57% this year; IIFL Securities says 'buy' it
These two diagnostics stocks are down 40-60% this year but brokerages sees more downside
Diagnostics sector may see a de-rating, sell Dr. Lal PathLabs, Metropolis Healthcare, says Antique Broking